{"tm":1686890303,"s":"MRK","news":[{"t":"Why Are IO Biotech Shares Trading Lower Today","dt":"Jun-14-23 12:42PM","a":"Benzinga","u":"https:\/\/finance.yahoo.com\/news\/why-io-biotech-shares-trading-164230113.html"},{"t":"Merck Enters The Ring In Weight Loss  But Novo, Lilly Could Be The Winners","dt":"12:05PM","a":"Investor's Business Daily","u":"https:\/\/finance.yahoo.com\/m\/faa927b8-53a0-3b22-bda4-2dd51cfc1f14\/merck-enters-the-ring-in.html"},{"t":"UPDATE 1-US Chamber of Commerce sues over government's drug pricing power","dt":"06:35PM","a":"Reuters","u":"https:\/\/finance.yahoo.com\/news\/1-us-chamber-commerce-sues-223519992.html"},{"t":"Merck (MRK) Outpaces Stock Market Gains: What You Should Know","dt":"Jun-08-23 05:45PM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/merck-mrk-outpaces-stock-market-214518145.html"},{"t":"FDA Accepts Application for Mercks KEYTRUDA\u00ae (pembrolizumab) Plus Chemotherapy as Treatment for Advanced or Unresectable Biliary Tract Cancer","dt":"06:45AM","a":"Business Wire","u":"https:\/\/finance.yahoo.com\/news\/fda-accepts-application-merck-keytruda-104500222.html"},{"t":"Merck Challenges U.S. Governments New Powers to Negotiate Drug Prices","dt":"05:25PM","a":"The Wall Street Journal","u":"https:\/\/finance.yahoo.com\/m\/b01874dc-b21b-3bd4-9435-27b082aac4f1\/merck-challenges-u.s..html"},{"t":"Merck sues U.S. government over Medicare drug pricing negotiation","dt":"03:40PM","a":"Yahoo Finance Video","u":"https:\/\/finance.yahoo.com\/video\/merck-sues-u-government-over-194002065.html"},{"t":"UPDATE 5-Merck sues US government to halt Medicare drug price negotiation","dt":"09:23AM","a":"Reuters","u":"https:\/\/finance.yahoo.com\/news\/1-merck-sues-us-government-132302450.html"},{"t":"Analyst Report: Merck &amp; Co Inc","dt":"07:20AM","a":"Argus Research","u":"https:\/\/finance.yahoo.com\/m\/30af09a5-c36a-3eca-81bc-c428eeab9433\/analyst-report%3A-merck-%26-co-inc.html"},{"t":"Merck to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference","dt":"06:45AM","a":"Business Wire","u":"https:\/\/finance.yahoo.com\/news\/merck-participate-goldman-sachs-44th-104500655.html"},{"t":"Moderna and Merck Announce mRNA-4157 (V940) in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated a Statistically Significant and Clinically Meaningful Improvement in Distant Metastasis-Free Survival in Patients with High-Risk Stage III\/IV Melanoma Following Complete Resection Versus KEYTRUDA","dt":"08:00AM","a":"ACCESSWIRE","u":"https:\/\/finance.yahoo.com\/news\/moderna-merck-announce-mrna-4157-120000108.html"},{"t":"KEYTRUDA\u00ae (pembrolizumab) Plus Chemotherapy Significantly Improved Overall Survival Versus Chemotherapy Alone as First-Line Treatment for Unresectable Advanced Pleural Mesothelioma","dt":"08:00AM","a":"Business Wire","u":"https:\/\/finance.yahoo.com\/news\/keytruda-pembrolizumab-plus-chemotherapy-significantly-120000217.html"},{"t":"New Pfizer RSV Vaccine Rolls Out Into Headwinds of Hesitancy","dt":"May-31-23 06:46PM","a":"The Wall Street Journal","u":"https:\/\/finance.yahoo.com\/m\/8373d3cb-918a-382b-8f9c-db51abfa62eb\/new-pfizer-rsv-vaccine-rolls.html"},{"t":"14 Best Biotech Stocks To Buy According To Hedge Funds","dt":"04:03AM","a":"Insider Monkey","u":"https:\/\/finance.yahoo.com\/news\/14-best-biotech-stocks-buy-080352111.html"},{"t":"Merck Announces Third-Quarter 2023 Dividend","dt":"02:45PM","a":"Business Wire","u":"https:\/\/finance.yahoo.com\/news\/merck-announces-third-quarter-2023-184500536.html"},{"t":"25 Most Prescribed Medication in the World","dt":"May-18-23 07:25AM","a":"Insider Monkey","u":"https:\/\/finance.yahoo.com\/news\/25-most-prescribed-medication-world-112510893.html"},{"t":"Drugmakers Eye $23 Billion Biotech Argenx Ahead of Key Data","dt":"10:21AM","a":"Bloomberg","u":"https:\/\/finance.yahoo.com\/news\/drugmakers-circle-23-billion-biotech-222514824.html"},{"t":"10 Great Earnings Reports Jim Cramer is Talking About","dt":"May-13-23 11:12AM","a":"Insider Monkey","u":"https:\/\/finance.yahoo.com\/news\/10-great-earnings-reports-jim-151254566.html"},{"t":"15 Biggest Immunotherapy Companies in the World","dt":"May-09-23 04:09PM","a":"Insider Monkey","u":"https:\/\/finance.yahoo.com\/news\/15-biggest-immunotherapy-companies-world-200959863.html"},{"t":"Moderna (MRNA) Q1 Earnings &amp; Sales Top Estimates, Stock Up 2%","dt":"May-04-23 02:01PM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/moderna-mrna-q1-earnings-sales-180106276.html"},{"t":"Insurers Can't Use War Argument: Court Rules in Favor of Merck in $1.4 Billion Cyberattack Coverage Case","dt":"May-03-23 03:52PM","a":"Benzinga","u":"https:\/\/finance.yahoo.com\/news\/insurers-cant-war-argument-court-195222656.html"},{"t":"Mercks Insurers On the Hook in $1.4 Billion NotPetya Attack, Court Says","dt":"May-02-23 03:42PM","a":"The Wall Street Journal","u":"https:\/\/finance.yahoo.com\/m\/5438606c-6ce7-3086-9d86-45ed0234caa5\/merck%E2%80%99s-insurers-on-the-hook.html"},{"t":"Update on FDA Advisory Committee Vote on LYNPARZA\u00ae (olaparib) Plus Abiraterone and Prednisone or Prednisolone in First-Line Metastatic Castration-Resistant Prostate Cancer","dt":"05:30PM","a":"Business Wire","u":"https:\/\/finance.yahoo.com\/news\/fda-advisory-committee-vote-lynparza-213000796.html"},{"t":"Company News for Apr 28, 2023","dt":"09:17AM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/company-news-apr-28-2023-131701707.html"},{"t":"Analyst Report: Merck &amp; Co., Inc.","dt":"01:10PM","a":"Morningstar Research","u":"https:\/\/finance.yahoo.com\/m\/2ecf8c1c-d32c-3062-b3a2-3e442010efe3\/analyst-report%3A-merck-%26-co.%2C.html"},{"t":"Drugmakers brace for serious headwinds ahead","dt":"10:00AM","a":"Yahoo Finance Video","u":"https:\/\/finance.yahoo.com\/video\/drugmakers-brace-serious-headwinds-ahead-140058567.html"},{"t":"Merck has strong quarter even as COVID-19 treatment tumble","dt":"08:43AM","a":"AP Finance","u":"https:\/\/finance.yahoo.com\/news\/merck-strong-quarter-even-covid-124314049.html"},{"t":"Merck beats first-quarter expectations on Keytruda, Gardasil strength","dt":"06:38AM","a":"Reuters","u":"https:\/\/finance.yahoo.com\/news\/merck-earnings-better-expected-keytruda-103855413.html"},{"t":"Merck Keeps Striking Out on Expanding Its Cancer-Drug Juggernaut","dt":"Apr-26-23 08:00AM","a":"The Wall Street Journal","u":"https:\/\/finance.yahoo.com\/m\/0bdbaac8-b30c-3be4-9094-f3d3ee93f99f\/merck-keeps-striking-out-on.html"},{"t":"Merck (MRK) to Report Q1 Earnings: What's in the Cards?","dt":"10:10AM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/merck-mrk-report-q1-earnings-141002503.html"},{"t":"Merck (MRK) Dips More Than Broader Markets: What You Should Know","dt":"Apr-19-23 05:45PM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/merck-mrk-dips-more-broader-214509042.html"},{"t":"Prometheus Biosciences, Inc. (RXDX) Stock Jumps 69.7%: Will It Continue to Soar?","dt":"03:19AM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/prometheus-biosciences-inc-rxdx-stock-071907296.html"},{"t":"Moderna stock plunges following mixed analyst reviews of cancer vaccine data","dt":"01:17PM","a":"Yahoo Finance","u":"https:\/\/finance.yahoo.com\/news\/moderna-stock-plunges-following-mixed-analyst-reviews-of-cancer-vaccine-data-171710140.html"}]}